The mTOR Inhibitor Everolimus in Combination With Azacitidine in Patients With Relapsed/Refractory Acute Myeloid Leukemia: A Phase Ib/Ii Study
Oncotarget - United States
doi 10.18632/oncotarget.13699
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 29, 2016
Authors
Publisher
Impact Journals, LLC